NDC 73309-280-01 - Ceftazidime Pentahydrate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 73309-280
Requested NDC: 73309-280-01
Package NDCs from labels: 73309-280-01
Manufacturer: BLUEBAY SHANDONG CO.,LTD
Effective date: 2021-04-09
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Ceftazidime Pentahydrate - BLUEBAY SHANDONG CO.,LTD	BLUEBAY SHANDONG CO.,LTD	2021-04-09	BULK INGREDIENT

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
73309-280-01	Ceftazidime Pentahydrate	100 g in 1 JAR	POWDER	100		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
73309-280	CEFTAZIDIME PENTAHYDRATE POWDER [BLUEBAY SHANDONG CO.,LTD]	1	1 package rows	20210410_8868b3c4-32d9-4b4b-806a-28d4da9ca16a.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	112c5457-8d71-49f5-b531-9761d7d38c93	2026-08-03	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR
TAZICEF	CEFTAZIDIME	Hospira, Inc.	40d48c5d-650e-461b-a67b-7e65772d1b92	2026-05-04	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR
AVYCAZ	CEFTAZIDIME, AVIBACTAM	Allergan, Inc.	d9c2803f-dc9c-4b19-b4a3-8303bc8c15fd	2025-04-30	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR
TAZICEF	CEFTAZIDIME	Hospira, Inc.	1ab5ae3e-e303-4499-4c89-472d7cc1e46c	2024-07-04	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR
Ceftazidime	CEFTAZIDIME	Sagent Pharmaceuticals	aec64360-8452-4987-a366-a5a4f8762ab6	2024-01-03	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR
Ceftazidime	CEFTAZIDIME	WG Critical Care, LLC	bcc81df2-20e3-4738-bfcf-301da883c1d9	2023-09-11	Warnings, Adverse reactions	Exact identifier unii: 9M416Z9QNR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.